Enanta Pharmaceuticals Inc (ENTA)
12.49
+0.49
(+4.08%)
USD |
NASDAQ |
May 31, 16:00
12.43
-0.06
(-0.48%)
After-Hours: 20:00
Enanta Pharmaceuticals 1 Year Total Returns (Daily): -46.81% for May 31, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 31, 2024 | -46.81% |
May 30, 2024 | -49.58% |
May 29, 2024 | -52.19% |
May 28, 2024 | -52.07% |
May 24, 2024 | -52.66% |
May 23, 2024 | -55.26% |
May 22, 2024 | -53.27% |
May 21, 2024 | -52.96% |
May 20, 2024 | -52.96% |
May 17, 2024 | -52.43% |
May 16, 2024 | -47.00% |
May 15, 2024 | -48.43% |
May 14, 2024 | -47.73% |
May 13, 2024 | -49.03% |
May 10, 2024 | -52.28% |
May 09, 2024 | -49.33% |
May 08, 2024 | -62.83% |
May 07, 2024 | -63.63% |
May 06, 2024 | -59.47% |
May 03, 2024 | -57.26% |
May 02, 2024 | -60.26% |
May 01, 2024 | -63.85% |
April 30, 2024 | -61.35% |
April 29, 2024 | -62.73% |
April 26, 2024 | -64.20% |
Date | Value |
---|---|
April 25, 2024 | -64.09% |
April 24, 2024 | -64.48% |
April 23, 2024 | -64.26% |
April 22, 2024 | -63.47% |
April 19, 2024 | -64.25% |
April 18, 2024 | -64.60% |
April 17, 2024 | -63.17% |
April 16, 2024 | -57.95% |
April 15, 2024 | -55.79% |
April 12, 2024 | -55.04% |
April 11, 2024 | -56.79% |
April 10, 2024 | -57.84% |
April 09, 2024 | -57.79% |
April 08, 2024 | -58.95% |
April 05, 2024 | -57.11% |
April 04, 2024 | -58.35% |
April 03, 2024 | -58.04% |
April 02, 2024 | -59.57% |
April 01, 2024 | -57.91% |
March 28, 2024 | -55.02% |
March 27, 2024 | -58.49% |
March 26, 2024 | -60.19% |
March 25, 2024 | -65.21% |
March 22, 2024 | -63.24% |
March 21, 2024 | -64.22% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-82.00%
Minimum
Oct 27 2023
114.8%
Maximum
Nov 05 2021
-21.77%
Average
-27.12%
Median
Oct 26 2020
1 Year Total Returns (Daily) Benchmarks
Madrigal Pharmaceuticals Inc | -15.13% |
Galectin Therapeutics Inc | 74.52% |
Viking Therapeutics Inc | 183.7% |
Akero Therapeutics Inc | -57.78% |
89bio Inc | -56.66% |